SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001401708-22-000118
Filing Date
2022-06-17
Accepted
2022-06-17 16:17:52
Documents
16
Period of Report
2022-06-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nstg-20220617.htm   iXBRL 8-K 61521
2 EX-10.1 nstg-2022ex101.htm EX-10.1 128823
3 EX-10.2 nstg-2022ex102.htm EX-10.2 66068
4 EX-10.3 nstg-2022ex103.htm EX-10.3 50347
5 EX-10.4 nstg-2022ex104.htm EX-10.4 46689
  Complete submission text file 0001401708-22-000118.txt   559439

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nstg-20220617.xsd EX-101.SCH 1946
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nstg-20220617_lab.xml EX-101.LAB 24137
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nstg-20220617_pre.xml EX-101.PRE 12548
10 EXTRACTED XBRL INSTANCE DOCUMENT nstg-20220617_htm.xml XML 10899
Mailing Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109
Business Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109 206-378-6266
NanoString Technologies Inc (Filer) CIK: 0001401708 (see all company filings)

IRS No.: 200094687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35980 | Film No.: 221024085
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences